Prioritising the research agenda for retention of participants in clinical trials: PRioRiTy II announces its results
Randomised clinical trials are the gold standard method for gathering evidence about health and care interventions. That said, randomised trials are not perfect, and many of them run into issues through the process of trial design and delivery. The PrioRiTy II work identified the most important questions to be answered about retention of participants in clinical trials.
Published: 12 March 2019